Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-18

Clinical Trial Update: Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on vaporized cannabis for pain in sickle cell disease (Phase 1/2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaporized Cannabis (Cannabis)

Snippet

Sponsor: University of California, San Francisco | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-18